Cargando…
Adalimumab induced pulmonary sarcoid reaction
Sarcoidosis is a multisystem granulomatous inflammatory disease of unknown etiology. There is evidence that Tumor Necrosis Factor alpha (TNF-α) antagonists are useful in the treatment of advanced or refractory disease. However, sarcoidosis-like reaction has been reported with TNF-α blockade in other...
Autores principales: | Bhargava, S., Perlman, D.M., Allen, T.L., Ritter, J.H., Bhargava, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920421/ https://www.ncbi.nlm.nih.gov/pubmed/26029514 http://dx.doi.org/10.1016/j.rmcr.2013.07.002 |
Ejemplares similares
-
Treatment of sarcoid granulomatous interstitial nephritis with adalimumab
por: Gupta, Roopali, et al.
Publicado: (2009) -
Sarcoid-Associated Bilateral Multifocal Choroiditis Secondary to Adalimumab
por: Wilkins, Carl Stanley, et al.
Publicado: (2021) -
Durvalumab induced sarcoid‐like pulmonary lymphadenopathy
por: Sanderson, Emma, et al.
Publicado: (2020) -
Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
por: Purcell, Victoria, et al.
Publicado: (2022) -
Immunotherapy-Induced Sarcoid-Like Reaction: A Shrewd Imitator
por: Yasin, Hassaan, et al.
Publicado: (2021)